Literature DB >> 19857080

Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.

Kürşad Yapar1, Kültiğin Cavuşoğlu, Ertan Oruç, Emine Yalçin.   

Abstract

The aim of the present study was to investigate the protective role of royal jelly (RJ) and green tea (GT) extracts on cisplatin (cDDP)-induced nephrotoxicity in adult albino mice. Albino mice were randomly divided into six groups: Group I (control) received a single intraperitoneal injection of isotonic saline (0.02 mL/g), Group II received a single intraperitoneal injection of cDDP (7 mg/kg of body weight), Group III received RJ (100 mg/kg of body weight), Group IV received GT (100 mg/kg of body weight), Group V received RJ (100 mg/kg of body weight) + cDDP (7 mg/kg of body weight), and Group VI received GT (100 mg/kg of body weight) + cDDP (7 mg/kg of body weight). The concentrations of blood urea nitrogen (BUN) and creatinine were evaluated. In addition, kidney samples were taken for determination of tissue malondialdehyde (MDA) and reduced glutathione (GSH) levels. In addition, histopathological changes in kidneys were investigated. The results indicated that no significant differences in MDA, GSH, BUN, and creatinine levels were observed among the control group and groups treated with RJ alone and GT alone (P > .05). However, there was a significant increase in BUN and creatinine parameters after cDDP application in Groups II, V, and VI. The mice treated with only cDDP exhibited an increase in serum BUN and creatinine levels when compared to Groups V and VI (P < .05). Moreover, cDDP-induced oxidative damage caused a significant decrease in GSH levels and a significant increase in MDA levels in kidneys (P < .05). RJ and GT supplementation attenuated cDDP-induced nephrotoxicity, which was manifested by stopping the elevation in serum creatinine and BUN levels. Moreover, RJ and GT supplementation restored GSH content and MDA production levels in the kidney tissue following cDDP treatment (P < .05). These products were also effective in protecting against cDDP-induced tissue damage in mouse kidneys. In conclusion, 100 mg/kg of body weight doses of RJ and GT provided protection against cDDP-induced nephrotoxicity, and both products can act as protector agents against cDDP-induced kidney damages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857080     DOI: 10.1089/jmf.2009.0036

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  6 in total

1.  Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo.

Authors:  Nada Oršolić; Nikola Car
Journal:  Tumour Biol       Date:  2014-03-29

Review 2.  Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.

Authors:  Siddesh Jaiman; Arun Kumar Sharma; Kulwant Singh; Deepa Khanna
Journal:  Eur J Clin Pharmacol       Date:  2013-08-09       Impact factor: 2.953

3.  Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin.

Authors:  Ali Karadeniz; Nejdet Simsek; Emre Karakus; Serap Yildirim; Adem Kara; Ismail Can; Fikrullah Kisa; Habib Emre; Mehmet Turkeli
Journal:  Oxid Med Cell Longev       Date:  2011-08-01       Impact factor: 6.543

4.  Protective effect of royal jelly on fertility and biochemical parameters in bleomycin-‎induced male rats.

Authors:  Tayebeh Amirshahi; Gholamreza Najafi; Vahid Nejati
Journal:  Iran J Reprod Med       Date:  2014-03

Review 5.  Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review.

Authors:  Saeid Heidari-Soreshjani; Majid Asadi-Samani; Qian Yang; Ali Saeedi-Boroujeni
Journal:  J Nephropathol       Date:  2017-02-16

Review 6.  Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2018-10-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.